Drug Repurposing for Rare Diseases 2022

Our annual conference highlights the role that drug repurposing can play in lowering the cost and accelerating the development of rare disease treatments.

The drug repurposing field has shifted after stepping into the limelight during the COVID-19 pandemic. The world is beginning to care about drug repurposing and is recognising the opportunities to repurpose a drug to treat an often rare and neglected condition.

Repurposing schemes, projects and ideas are all in place to accelerate access to desperately needed medicines - the answers have been right under our noses all along!

At Drug Repurposing for Rare Diseases 2022, Beacon is shifting its programme to match the new drug repurposing landscape; one that's filled with hope, promise and innovation. Instead of inspiring attendees with case studies on how you could succeed with a repurposing project, we're taking a more active approach by sharing how you can take your repurposing project to the next level.

Beacon has seen numerous projects come to the forefront that have drastically changed the repurposing landscape. These projects are making a measurable difference in the lives of patients. Structural changes have been introduced to improve how the scientific community approaches drug repurposing projects. Every innovation is advancing repurposing projects in a meaningful, patient-centric way.

Beacon's programme will highlight those who dared to believe in drug repurposing and are bringing repurposed medicines to patients at an accelerated rate.

Más información


America Square Conference Centre, London


10 de octubre de 2022
09:00 – 18:30h.